NorthWest Biotherapeutics Inc (NWBO)

[sentiment_stocks]

It’s my understanding that when the DCVax-L MHRA application was filed (back on December 21), this was done after the company had received confirmation (a simple receipt from the MHRA) that the application had indeed been received. It’s just a receipt… it’s the “validation” of which you note…. something like what the SEC provides when a filing is made on Edgar.

The company then announced their filing of the MAA with the MHRA, received their "validation" as you call it (basically a receipt), and that’s the end of it.

After that, the old adage “silence is golden” kicks in and all discourse between Northwest and the regulator is kept private. I believe that the company takes the position that the regulators do not look favorably on any type of public announcements regarding the status of the MAA with the MHRA until such time as something material happens (and that wouldn’t be that the MHRA is in receipt of the MAA).

Therefore, looking for any other type of “validation” regarding the MAA and its application status with the MHRA, and I mean this nicely, is a complete waste of our time because we’ve already been given it. They would never have released the December 21, 2023 PR if they’d not received confirmation that the MHRA had received it. End of story.